Tremelimumab

Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and lung cancer.

Product Specifications

CAS Number

745013-59-6

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Others

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

124120-AP 100 µL

C21orf2 (Protein C21orf2, C21orf-HUMF09G8.5, YF5/A2) (AP) discontinued

Ask

View Details

STJ29929 100 µl

Anti-UTP14A antibody

Ask

View Details

CEK0157 96 Tests

Mouse PDGFC ELISA Kit

Ask

View Details

NBP3-00157AF405 0.1 mL

Rabbit Polyclonal PDE1C Antibody [Alexa Fluor 405]

Ask

View Details

260835-01 500 mg

(R) -3-Amino-3- (4-cyanophenyl) propionic acid

Ask

View Details

260835-02 1 g

(R) -3-Amino-3- (4-cyanophenyl) propionic acid

Ask

View Details